Abstract
Tumour cells traverse epithelial and endothelial basement membranes during the successive stages of the metastatic process. At the transition from in situ to invasive carcinoma, local dissolution of the basement membrane is observed microscopically1,2, and coincides with tumour cell invasion of the underlying stroma. Tumour cells further traverse the endothelial basement membrane during entry into and egress from blood vessels3–5. Electron microscopic studies have shown local dissolution of basement membrane at its area of contact with invading tumour cells, suggesting an enzymatic mechanism3,6,7. Basement membranes are resilient structures which present a mechanical barrier to invasion8. Type IV collagen is a major structural protein of basement membranes and is chemically and genetically distinct from stroma collagen types I and III and cartilage collagen type II9,10. Previously characterised animal collagenases which cleave collagen types I; II and III fail to degrade type IV collagen11,12. We have recently purified about 1,000-fold and characterised a neutral protease activity preferential for type IV collagen from metastatic tumour cells and shown that it (1) produces specific degradation products, (2) has a molecular weight of 65,000, (3) is not plasmin or a cathepsin, by pH and inhibitor studies, and (4) does not significantly degrade other collagens or fibronectin12,13. Here we extend the relevance of this finding by quantitating the ability of several murine tumour cell lines of known metastatic potential to degrade type IV collagen. The cell lines with the highest incidence of spontaneous metastasis exhibit the greatest level of type IV collagen-degrading activity in two different assays using either living cells or media obtained from cell cultures.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ozello, L. Am. J. Path. 35, 887–899 (1959).
Rubio, C. A. & Biberfeld, P. Acta path. microbiol. scand. A83, 744–748 (1975).
Vlaeminck, M. N., Adenis, L., Mouton, Y. & Demaille, A. Int. J. Cancer 10, 619–631 (1972).
Roos, E. & Dingemans, K. P. Biochim. biophys. Acta 560, 135–166 (1979).
Liotta, L. A., Kleinerman, J., Catanzaro, D. & Rynbrandt, D. J. natn. Cancer Inst. 58, 1427–1431 (1977).
McKinney, R. & Singh, B. Oral Surg. 44, 875–888 (1977).
Babai, F. J. ultrastruct. Res. 56, 287–303 (1976).
Vracko, R. Am. J. Path. 77, 314–346 (1974).
Kefalides, N. A. Int. Rev. connective Tissue Res. 6, 63–104 (1973).
Kefalides, N. A. Biochem. biophys. Res. Commun. 45, 226–234 (1971).
Wooley, D. E., Glanville, R. W., Roberts, D. R. & Evanson, J. M. Biochem. J. 169, 265–276 (1978).
Liotta, L. A., Abe, S., Gehron Robey, P. & Martin, G. R. Proc. natn. Acad. Sci. U.S.A. 76, 2268–2272 (1979).
Liotta, L. A., Garbisa, S., Tryggvason, K., Gehron-Robey, P. & Martin, G. R. Am. Ass. Cancer Res. Proc. 17th A. Meet. 235 (1979).
Fidler, I. J. Nature new Biol. 242, 148–149 (1973).
Fidler, I. J. & Kripke, M. L. Science 197, 893–895 (1977).
Liotta, L. A., Vembu, D., Saini, R. & Boone, C. J. natn. Cancer Inst. 38, 1231–1236 (1978).
Boone, C. W., Takeichi, N., Eaton, S. & Paranjpe, M. Science 204, 177–179 (1979).
Orkin, R. W. et al. J. exp. Med. 145, 204–220 (1977).
Timpl, R., Martin, G. R., Bruckner, P., Wick, G. & Weidemann, H. Eur. J. Biochem. 84, 43–52 (1978).
Garbisa, S., Tryggvason, K., Foidart, J. M. & Liotta, L. A. (submitted).
Nicolson, G. L. Scient. Am. 240, 66–76 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liotta, L., Tryggvason, K., Garbisa, S. et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67–68 (1980). https://doi.org/10.1038/284067a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/284067a0
This article is cited by
-
Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours
Nature Nanotechnology (2024)
-
Cell volume expansion and local contractility drive collective invasion of the basement membrane in breast cancer
Nature Materials (2023)
-
Relationship between Trace Elements and Matrix Metalloproteinases 2 and 9 and their Tissue Inhibitors in Medullary Thyroid Carcinoma
Biological Trace Element Research (2023)
-
Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway
Chinese Medicine (2022)
-
A curcumin analog CA-5f inhibits urokinase-type plasminogen activator and invasive phenotype of triple-negative breast cancer cells
Toxicological Research (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.